TY  - GEN
AU  - Rossello, Xavier
AU  - Barrabés, José A
AU  - Piepoli, Massimo
AU  - Dominguez-Rodriguez, Alberto
AU  - Sánchez, Pedro L
AU  - Anguita, Manuel
AU  - Raposeiras-Roubín, Sergio
AU  - Grigis, Giulietta
AU  - Agüero, Jaume
AU  - Owen, Ruth
AU  - Pocock, Stuart
AU  - Pérez-García, Carlos Nicolás
AU  - Escalera, Noemí
AU  - Kallmeyer, Andrea
AU  - Sionis, Alessandro
AU  - Staszewsky, Lidia
AU  - Torres, Alfonso
AU  - Barquero, Rocio
AU  - Fernández-Vazquez, Felipe
AU  - Marín, Francisco
AU  - Vetrano, Alfredo
AU  - Pastor, Pablo
AU  - Fuster, Valentín
AU  - Latini, Roberto
AU  - Ibanez, Borja
PY  - 2026
UR  - https://hdl.handle.net/20.500.12105/27357
AB  - Current guidelines recommend beta-blocker therapy after myocardial infarction (MI) regardless of left ventricular ejection fraction (LVEF). However, recent trials question their benefit in patients with preserved LVEF. No study has yet compared...
LA  - eng
PB  - Oxford University Press
KW  - Acute coronary syndrome
KW  - Chronic coronary syndrome
KW  - Landmark analysis
KW  - Randomized controlled trial
KW  - beta blockers
TI  - Effect of beta blockers in acute and chronic coronary syndromes without reduced ejection fraction: a landmark analysis from the REBOOT trial.
TY  - research article
ER  -